1 Min Read
Nov 30 (Reuters) - Newron Pharmaceuticals SpA:
* ZAMBON ANNOUNCES APPROVAL AND ARTG LISTING OF SAFINAMIDE IN AUSTRALIA FOR TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.